Vaccine against RSV
作者： Jerome H. H. V. Custers , Jort Vellinga , Katarina Radosevic , Myra N. Widjojoatmodjo
DOI:
关键词:
摘要: The invention provides a vaccine against respiratory syncytial virus (RSV), comprising recombinant human adenovirus of serotype (26) that comprises nucleic acid encoding RSV F protein or immunologically active part thereof.
google.it 参考文章(98)
Pele Chong, Charles Sia, Hsiao-Yun Shao, Yen-Hung Chow, Human respiratory syncytial virus (rsv) vaccine ,(2009)
Peter L. Collins, Brian R. Murphy, Vaccines against Human Respiratory Syncytial Virus Perspectives in Medical Virology. ,vol. 14, pp. 233- 278 ,(2006) , 10.1016/S0168-7069(06)14008-2
Jason G.D. Gall, Respiratory syncytial virus (rsv) vaccine ,(2011)
Duncan L. McVey, Alena Lizonova, Joseph T. Bruder, Imre Kovesdi, Douglas E. Brough, Complementary adenoviral systems and cell lines ,(1995)
Daniel P. Palermo, Fritz M. Rottman, Richard P. Woychik, Edward C. Goodwin, Leonard E. Post, Darrell R. Thomsen, Use of a bgh gdna polyadenylation signal in expression of non-bgh polypeptides in higher eukaryotic cells ,(1989)
Erno Pungor, Elisabeth Lehmberg, Stabilized formulations of adenovirus ,(2003)
Lars Hovgaard, Sven Frokjaer, Marco van de Weert, Pharmaceutical Formulation Development Of Peptides And Proteins ,(2009)
Klaus Ueberla, Thomas Grunwald, Rsv f-protein and its use ,(2007)
Joel R. Haynes, Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps ,(2010)
David Adrianus Theodorus Maria Zuijdgeest, Ronald Vogels, Menzo Jans Emco Havenga, Packaging cells for recombinant adenovirus ,(2004)